Role of Fiber Shaft Length in Tumor Targeting with Ad5/3 Vectors

被引:1
|
作者
Richter, Maximilian [1 ]
Wang, Hongjie [1 ]
Lieber, Andre [1 ]
机构
[1] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA
关键词
oncolytic virus; serotype; 3; desmoglein; 2; coagulation factor X; ONCOLYTIC ADENOVIRUS; INTRAVENOUS-INJECTION; GENE-TRANSFER; DESMOGLEIN; IN-VITRO; EXPRESSION; THERAPY; CELLS; TRANSDUCTION; FLEXIBILITY;
D O I
10.3390/genes13112056
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Desmoglein 2 (DSG2) is overexpressed in many epithelial cancers and therefore represents a target receptor for oncolytic viruses, including Ad5/3-based viruses. For most Ad serotypes, the receptor-binding fiber is composed of tail, shaft, and knob domains. Here, we investigated the role of the fiber shaft in Ad5/3 tumor transduction in vitro and in human DSG2-transgenic mice carrying human DSG2(high) tumors. DSG2tg mice express DSG2 in a pattern similar to humans. We constructed Ad5/3L (with the "long" Ad5 shaft) and Ad5/3S (with the "short" Ad3 shaft) expressing GFP or luciferase. In in vitro studies we found that coagulation factor X, which is known to mediate undesired hepatocyte transduction of Ad5, enhances the transduction of Ad5/3(L), but not the transduction of Ad5/3(S). We therefore hypothesized that Ad5/3(S) would target DSG2(high) tumors while sparing the liver after intravenous injection. In vivo imaging studies for luciferase and analysis of luciferase activity in isolated organs, showed that Ad5/3(L) vectors efficiently transduced DSG2(high) tumors and liver but not normal epithelial tissues after intravenous injection. Ad5/3(S) showed minimal liver transduction, however it failed to transduce DSG2(high) tumors. Further modifications of the Ad5/3(S) capsid are required to compensate for the lower infectivity of Ad5/3(S) vectors.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Mechanism of Ad5 vaccine immunity and toxicity: Fiber shaft targeting of dendritic cells
    Cheng, Cheng
    Gall, Jason G. D.
    Kong, Wing-pui
    Sheets, Rebecca L.
    Gomez, Phillip L.
    King, C. Richter
    Nabel, Gary J.
    PLOS PATHOGENS, 2007, 3 (02) : 239 - 245
  • [2] Targeting of Ad5 vectors using designed protein ligands
    Belousova, Natalya
    Mikheeva, Galina
    Krasnykh, Victor
    HUMAN GENE THERAPY, 2007, 18 (10) : 1042 - 1042
  • [3] A novel library of fiber pseudotyped Ad5 vectors for virotherapy applications
    Uusi-Kerttula, Hanni
    Vanova, Jana
    Davies, James A.
    Parker, Alan L.
    HUMAN GENE THERAPY, 2017, 28 (08) : A31 - A31
  • [4] Targeting of adenovirus serotype 5 (Ad5) and 5/47 pseudotyped vectors in vivo: Fundamental involvement of coagulation factors and redundancy of CAR binding by Ad5
    Waddington, Simon N.
    Parker, Alan L.
    Havenga, Menzo
    Nicklin, Stuart A.
    Buckley, Suzanne M. K.
    Mcvey, John H.
    Baker, Andrew H.
    JOURNAL OF VIROLOGY, 2007, 81 (17) : 9568 - 9571
  • [5] Biodistribution of Fiber-Chimeric Ad5/3 Vectors in DSG2-Transgenic Mice
    Richter, Maximilian
    Yumul, Roma
    Wang, Hongjie
    Nettelbeck, Dirk
    Lieber, Andre
    MOLECULAR THERAPY, 2013, 21 : S186 - S186
  • [6] Ad5 and Ad3 chimeric fiber travels into the cell without the CAR
    Amin, KM
    CANCER BIOLOGY & THERAPY, 2003, 2 (05) : 516 - 517
  • [7] Role of Hexon- and Fiber-Specific Antibodies in Ad5 Neutralization
    Bradley, R. R.
    Barouch, D. H.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2011, 27 (10) : A90 - A90
  • [8] Hexon Hypervariable Region-Modified Adenovirus Type 5 (Ad5) Vectors Display Reduced Hepatotoxicity but Induce T Lymphocyte Phenotypes Similar to Ad5 Vectors
    Teigler, Jeffrey E.
    Penaloza-MacMaster, Pablo
    Obeng, Rebecca
    Provine, Nicholas M.
    Larocca, Rafael A.
    Borducchi, Erica N.
    Barouch, Dan H.
    CLINICAL AND VACCINE IMMUNOLOGY, 2014, 21 (08) : 1137 - 1144
  • [9] Superior infectivity of the fiber chimeric oncolytic adenoviruses Ad5/35 and Ad5/3 over Ad5-delta-24-RGD in primary glioma cultures
    Stepanenko, Aleksei A.
    Sosnovtseva, Anastasiia O.
    Valikhov, Marat P.
    Chernysheva, Anastasia A.
    Cherepanov, Sergey A.
    Yusubalieva, Gaukhar M.
    Ruzsics, Zsolt
    Lipatova, Anastasiia, V
    Chekhonin, Vladimir P.
    MOLECULAR THERAPY-ONCOLYTICS, 2022, 24 : 230 - 248
  • [10] Chimeric Ad5 vectors expressing the short fiber of Ad41 show reduced affinity for human intestinal epithelium
    Kesisoglou, Filippos
    Charnberlain, Joel R.
    Schmiedlin-Ren, Phyllissa
    Kaz, Andrew
    Fleisher, David
    Roessler, Blake
    Zimmermann, Ellen M.
    MOLECULAR PHARMACEUTICS, 2005, 2 (06) : 500 - 508